Future Science Group
Browse
Supp_Table_1 (1).docx (15.02 kB)

Liquid biopsy for KRAS, NRAS and BRAF mutation testing in advanced colorectal cancer patients: the Argentinean experience Supplementary Table 1

Download (15.02 kB)
dataset
posted on 2022-11-17, 15:12 authored by Leandro Guttlein, Maria R Luca, Federico Esteso, Cristobal Fresno, Javier Mariani, Mercedes Otero Pizarro, Esteban Brest, Solange Starapoli, Kevin Kreimberg, Paula Teves, Andrea Mendoza Bertelli, Maria R Girotti, Ruben Salanova, Juan M O’Connor

Liquid biopsy for KRAS, NRAS and BRAF

mutation testing in advanced colorectal

cancer patients: the Argentinean experience Table 1

Funding

The development of this publication was financially supported by Merck KGaA, Darmstadt, Germany through an independent medical writing grant. The views and opinions described in this publication do not necessarily reflect those of the grantor. All authors receives honoraria for advisory board and research grants from Merck, outside the current study. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

History

Usage metrics

    Future Oncology

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC